Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris

We report two cases of alopecia diffusa during the treatment of psoriasis vulgaris with interleukin (IL)-17 inhibitors. Psoriasis is one of the most common immune-mediated chronic skin diseases, strongly associated with IL-17A. Clinically, the monoclonal antibodies to IL-17A or its receptor, IL-17R,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Makiko, Akeda, Tomoko, Kondo, Makoto, Habe, Koji, Yamanaka, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489098/
https://www.ncbi.nlm.nih.gov/pubmed/31097934
http://dx.doi.org/10.1159/000499030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489098/
https://www.ncbi.nlm.nih.gov/pubmed/31097934
http://dx.doi.org/10.1159/000499030

Ejemplares similares